DOI: 10.1055/s-00000054

Pharmacopsychiatry

Issue 02 · Volume 39 · March 2006 DOI: 10.1055/s-002-4764

Original Paper

  • 41
    Müller, M. J.; Regenbogen, B.; Sachse, J.; Eich, F. X.; Härtter, S.; Hiemke, C.:

    Gender Aspects in the Clinical Treatment of Schizophrenic Inpatients With Amisulpride: A Therapeutic Drug Monitoring Study

  • 47
    Karow, A.; Schnedler, D.; Naber, D.:

    What Would The Patient Choose? Subjective Comparison of Atypical and Typical Neuroleptics

  • 52
    Yukimasa, T.; Yoshimura, R.; Tamagawa, A.; Uozumi, T.; Shinkai, K.; Ueda, N.; Tsuji, S.; Nakamura, J.:

    High-Frequency Repetitive Transcranial Magnetic Stimulation Improves Refractory Depression by Influencing Catecholamine and Brain-Derived Neurotrophic Factors

  • 60
    Marchesi, C.; Cantoni, A.; Fontò, S.; Giannelli, M. R.; Maggini, C.:

    Predictors of Symptom Resolution in Panic Disorder After One Year of Pharmacological Treatment: A Naturalistic Study

  • 66
    Gastpar, M.; Singer, A.; Zeller, K.:

    Comparative Efficacy and Safety of a Once-Daily Dosage of Hypericum Extract STW3-VI and Citalopram in Patients with Moderate Depression: A Double-Blind, Randomised, Multicentre, Placebo-Controlled Study

    • Letter

  • 76
    Luebbe, G.; Kropp, S.; Harms, E.; Ziegenbein, M.:

    Extensive Weight Loss in a Patient with Schizophrenia after Switching from Olanzapine to Aripiprazole

  • 77
    Mouaffak, F.; Gourevitch, R.; Baup, N.; Lôo, H.; Olié, J. P.:

    Interrelations between Lithium Therapy, Auto-Immune Thyroiditis and TSH

  • 79
    Pilhatsch, M. K.; Burghardt, R.; Wandinger, K.-P.; Bauer, M.; Adli, M.:

    Augmentation with Atomoxetine in Treatment-Resistant Depression with Psychotic Features

  • 80
    Ritchie, C. W.; Cappai, R.; Masters, C.:

    Clioquinol Treatment in Familiar Early Onset of Alzheimer’s Disease